Published in Curr Protoc Immunol on August 01, 2010
International network of cancer genome projects. Nature (2010) 20.35
A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics (2008) 6.45
Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles. J Proteome Res (2009) 3.77
Toward a confocal subcellular atlas of the human proteome. Mol Cell Proteomics (2007) 2.80
Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics (2013) 2.53
Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res (2006) 2.46
A global view of protein expression in human cells, tissues, and organs. Mol Syst Biol (2009) 2.41
Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics (2009) 2.36
The human proteome project: current state and future direction. Mol Cell Proteomics (2011) 2.34
Antibodypedia, a portal for sharing antibody and antigen validation data. Mol Cell Proteomics (2008) 2.34
The genome sequence of Mycoplasma mycoides subsp. mycoides SC type strain PG1T, the causative agent of contagious bovine pleuropneumonia (CBPP). Genome Res (2004) 2.33
The biotin-streptavidin interaction can be reversibly broken using water at elevated temperatures. Electrophoresis (2005) 2.12
Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells. Nat Methods (2013) 2.05
A Populus EST resource for plant functional genomics. Proc Natl Acad Sci U S A (2004) 2.04
ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods (2007) 2.04
Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation. Proc Natl Acad Sci U S A (2008) 1.99
Prediction of the human membrane proteome. Proteomics (2010) 1.85
CXCR4 and cancer. Pathol Int (2010) 1.73
Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate. Nucleic Acids Res (2010) 1.57
Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry. J Nucl Med (2009) 1.54
Anti-idiotypic protein domains selected from protein A-based affibody libraries. Proteins (2002) 1.52
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. J Transl Med (2010) 1.51
Display of proteins on bacteria. J Biotechnol (2002) 1.48
A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Mol Cell Proteomics (2007) 1.43
Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Diagn Pathol (2012) 1.38
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial. Breast Cancer Res Treat (2013) 1.38
The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD. Mol Biol Cell (2007) 1.33
Expression and subcellular distribution of novel glomerulus-associated proteins dendrin, ehd3, sh2d4a, plekhh2, and 2310066E14Rik. J Am Soc Nephrol (2007) 1.33
SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol (2011) 1.27
Determination of binding specificities in highly multiplexed bead-based assays for antibody proteomics. Mol Cell Proteomics (2006) 1.22
Extensive linkage disequilibrium in small human populations in Eurasia. Am J Hum Genet (2002) 1.20
Glcci1 deficiency leads to proteinuria. J Am Soc Nephrol (2011) 1.19
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule. J Mol Biol (2008) 1.19
Automated Analysis of Human Protein Atlas Immunofluorescence Images. Proc IEEE Int Symp Biomed Imaging (2009) 1.18
Epitope mapping of antibodies using bacterial surface display. Nat Methods (2008) 1.18
Detection and analysis of low-abundance cell-surface biomarkers using enzymatic amplification in microfluidic droplets. Angew Chem Int Ed Engl (2009) 1.17
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer. BMC Cancer (2012) 1.17
Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer. BMC Cancer (2010) 1.17
Biotechnological applications for surface-engineered bacteria. Biotechnol Appl Biochem (2004) 1.17
RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer. Transl Oncol (2011) 1.16
Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues. Mol Cell Proteomics (2003) 1.15
Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study. J Transl Med (2011) 1.15
Non-immunoglobulin based protein scaffolds. Curr Opin Biotechnol (2011) 1.14
Sun1 forms immobile macromolecular assemblies at the nuclear envelope. Biochim Biophys Acta (2008) 1.12
Contribution of antibody-based protein profiling to the human Chromosome-centric Proteome Project (C-HPP). J Proteome Res (2012) 1.11
A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics (2009) 1.11
Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli. Biotechnol Appl Biochem (2002) 1.10
Antibody suspension bead arrays within serum proteomics. J Proteome Res (2008) 1.08
Optimizing membrane protein overexpression in the Escherichia coli strain Lemo21(DE3). J Mol Biol (2012) 1.07
Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides. J Biotechnol (2006) 1.07
Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule. Nucl Med Biol (2007) 1.06
Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo. PLoS Biol (2010) 1.05
Microbead display of proteins by cell-free expression of anchored DNA. J Biotechnol (2003) 1.04
In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics. Cancer Biother Radiopharm (2005) 1.03
Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice. Eur J Nucl Med Mol Imaging (2006) 1.02
Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs. Drug Metab Dispos (2009) 1.02
A whole-genome bioinformatics approach to selection of antigens for systematic antibody generation. Proteomics (2008) 1.01
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression. Diagn Pathol (2011) 1.00
Transcriptional responses of Paxillus involutus and Betula pendula during formation of ectomycorrhizal root tissue. Mol Plant Microbe Interact (2004) 0.99
Structure, specificity, and mode of interaction for bacterial albumin-binding modules. J Biol Chem (2001) 0.99
Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. J Nucl Med (2006) 0.99
Comprehensive study of mtDNA among Southwest Asian dogs contradicts independent domestication of wolf, but implies dog-wolf hybridization. Ecol Evol (2011) 0.99
Automated analysis and reannotation of subcellular locations in confocal images from the Human Protein Atlas. PLoS One (2012) 0.99
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer. BMC Cancer (2013) 0.99
CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer. EMBO Mol Med (2013) 0.99
Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer. J Ovarian Res (2012) 0.98
Serum microarrays for large scale screening of protein levels. Mol Cell Proteomics (2005) 0.98
Systematic antibody and antigen-based proteomic profiling with microarrays. Expert Rev Mol Diagn (2011) 0.97
Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin. Protein Sci (2002) 0.97
Neuronal calcium-binding proteins 1/2 localize to dorsal root ganglia and excitatory spinal neurons and are regulated by nerve injury. Proc Natl Acad Sci U S A (2014) 0.97
A single fixation protocol for proteome-wide immunofluorescence localization studies. J Proteomics (2009) 0.97
High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma. Diagn Pathol (2012) 0.97
Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model. Proteome Sci (2011) 0.96
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer. BMC Urol (2013) 0.96
Selective enrichment of monospecific polyclonal antibodies for antibody-based proteomics efforts. J Chromatogr A (2004) 0.96
Creation of an antibody-based subcellular protein atlas. Proteomics (2010) 0.96
Engineered affinity proteins--generation and applications. J Biotechnol (2009) 0.95
Engineered affinity proteins for tumour-targeting applications. Biotechnol Appl Biochem (2009) 0.95
A human protein atlas based on antibody proteomics. Curr Opin Mol Ther (2006) 0.95
Secretagogin is a Ca2+-binding protein specifying subpopulations of telencephalic neurons. Proc Natl Acad Sci U S A (2009) 0.94
Systematic validation of antibody binding and protein subcellular localization using siRNA and confocal microscopy. J Proteomics (2012) 0.94
Comparative protein profiling of serum and plasma using an antibody suspension bead array approach. Proteomics (2010) 0.94
Tissue profiling of the mammalian central nervous system using human antibody-based proteomics. Mol Cell Proteomics (2009) 0.94
Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases. Diagn Pathol (2013) 0.94
Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification. PLoS One (2013) 0.94
Autoantibody profiling in multiple sclerosis using arrays of human protein fragments. Mol Cell Proteomics (2013) 0.94
Selection of protein epitopes for antibody production. Biotechniques (2005) 0.93
The correlation between cellular size and protein expression levels--normalization for global protein profiling. J Proteomics (2008) 0.93
A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry. Protein Eng Des Sel (2008) 0.93
Site-specifically conjugated anti-HER2 Affibody molecules as one-step reagents for target expression analyses on cells and xenograft samples. J Immunol Methods (2006) 0.93
Exploring epitopes of antibodies toward the human tryptophanyl-tRNA synthetase. N Biotechnol (2009) 0.92
A novel flow cytometry-based method for analysis of expression levels in Escherichia coli, giving information about precipitated and soluble protein. J Biotechnol (2005) 0.92
Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule. Biotechnol Appl Biochem (2009) 0.92